(Dosage Form) 1. !"#$%&
1.1 #'&( (Tablet) - #'&( %(!"*'*(+#, - , Ventolin tablet, Gas tablet - #'&( %(#, - (Coated tablets) @ " #$ %&'() (Sugar coated tablets) ! MTV, B.complex @ " #$ %&'567 (Film coated tablets) #$ ! !% & Brufen, Inderal @ Enteric-coated tablets ' ( ) ! * ( )*( +, - (* . ! * Bisacodyl, Aspent - #'&('./+ 0% (Sublingual tablets)
?@ABCDEF$G #H @$I$JK LG &$M"NOPGD( Q$"F GRK @''FS HN" &$ (First pass metabolism) Isordil-SL (Hartsort) VG)" #$PGD( FWX'W@Y''" #$C$Q$"A&() ?@)PSG "ABCDE GR KAXAZ$R @"VIA$I$J?A@''R $DS - #'&( %(//12.% (Orally disintegrating tablet) W\" #$NOYAXH" RH$ #H]"P RWA P@"@ HF AD 1 N S@L)SX'KIGW^H"NOF LV %N("H #$ "F$G KIGW^H"NOGR?)AX$WD_`R SH KIGW^H"NOGR N"R$ H JORY' RA W\ 2 D$ 1. #'&( %( #&2 (Fast dissolving tablet) "?@@"" RH$ #H &OLXKXL()"WD_ #AG" HDCNX'W@ Q$"HR #$"'D( YGHA&"SXR #$"@"Q$"F ?) W\GR$&O() Nemulid MD (MD " ?A mouth dissolving ) 2. #'&( %(//12#&2 (Fast disintegrating tablet) W\" #$NOYAA@?"XH W\YAIF$G" R H$ #H &OLXKXL()" N"R #AG" S@AX'XH"NONWfgS &OR%HF %RL] &OLXKXLA$PR $DS Q$" %&' YAI`R"$GH"567 D$ enteric coated )PSG DO%H%RL]PL]H@NON%H &(LIR A'L" Prevacid FDT "N(LVHR" #$'D( YGHA&"SXR?A #$"YAA@?" W\ #$YAI #Ai Q$"F GR$&O() /*',2 #,!0 2#'&( % -% @)PSGL %&'YAIYA )PSGXH"VIAA$PA@ @)"F$G - #'&(!". +#,!0 2 (Chewable tablets) Gelusil, Air-X, Calcium sandoz forte junior, singulair 5 mg - #'&(34 (Effervescent tablets)
1 W\" #$NOPSG5RYAoL%7'F$AF$7 &OLXKXLAX'() CDR, Cal-D Vita, Cal. Fort, Nac long, Fluimucil- A 600 mg " #$5I^?@VIA$I$JF$G$NAH D$ #$C$ Y ?@%YRAH @AKD"s R"AAH HDCNX'W@?@GR @""P()PSG AD$5R5I^Y@@"?S$ ?5RYAoLS"FWYGH?JR$&O" - #'&(567% % (Sustain-released) XARG"$GH" SR, LR, Retard, Control release, LA, -Dur Imdur, Bezalip retard, Trental, Depakin chrono 500, Cardil CR, Distaclor-MR, Klacid-MR, Diamicron MR /0%1 2)2()3 4 /4* 2 +, . * & . 2 2. slowed-release tablet (SR) . 2( D /0%1 4 &,- .( . extended-release capsule (XR) . 2( D /0%1 4 &,- .( . K )*( - ( . ( 2 . prolonged-release tablet (PR) . 2( D /0%1 4 &,- .( . modified-release tablet (MR) . 2( D * ( D - #'&( %08 Madopar 125 mg - ' (Lozenges, Troches) P GPWAPSG"@"A Gi "YAG ?#'% "v &( 1.2 ,: (Capsules ) -Y%WI D$ Vitamin E, Vitamin A -Y%WI D$Y`#R Essential -Y%WI D$NWA )$GH" ?D Tetracyclin 1.3 @ (Powders) -Oral powder P GX'W@ Amoxycillin dry syrup, Forlax, Fluimucil, Questran, Smecta, Charcoal, Meiact Y@N &O N"A R= sachet ( ) Viatril sachet, Flexa sachet -Dusting powder P G]"A &OS &O $A LN"$LN P Gv &(AX'YKNOF JA Zeasorb 1.4 #%& (Suppositories) - #%&2 %1 ABCDE z@NO (Local effect) Proctosedyl ,Glycerin suppo. Y@ABCDEXOH RA" (systemic effect) &O $I$JK LG &$'D H_HSXA "AX XA "$F`G "YAG ?N" (gravol suppo.) - #%& , ( (Vaginal suppositories) Gynecon, Canesten
2. !"#$%# 2 2.1 %08 .J (Solution) W\L@"PL "GR "'GHWA (Gargle S& mouthwashs) C-20, Difflam, Iliadrin drop 2.2 %08 # -"' (Syrups) W\L@"NON() (sucrose) KL"I &OPSGX'W@R "`J( CPM syrup Wf??s'X?@N D$ sugar free (F PL ()) Y P GLPSG%HSHNOF PSGXRR sorbital saccharin aspartame Y sucrose 2.3 #:L (Elixirs) 2 W\L@"PLNONYA|7KL"I 5-15% &O H"@"XH"L)%Xg NLSSH Dimetane elixir, Phenobarb elixir, Bisolvon elixir, 2.4 JO/ (Spirits) W\L@"PL`RLS@ S"R "NONYA|7KL"I 60-90 % NADOS Peppermint spirit, Aromatic ammonia spirit 2.5 #QL (Tinctures) W\"()NONL HKL W\YA|7 W\L HPSg DR ?7SSDR%7 DR ?7FQ$N 2.6 %08 2%/ % (Suspension) NXH H"PSGXH"NO@"()F % "F$G A@?"XHY`H"P()A@L""F$G Suspending agent) NX(R D$X'W@ Alum milk, Kaolin, Motilium, Junifen Y@ D$P G]"A Calamine 2.7 %08 2% (Emulsion) W\"()NOW@A'$GH"`R SH 2 D$ NOKL `GAXF F$G ( ()AX'()X) Q$"P GL emulsifying agent H"PSGHAXF$G Liquid paraffin emulsion, Agarol, Sevensea, ()XX'W 2.8 %08 @J' (Mixtures) W\"()NON@A`RXH"A@?""I P()A@L"" &OX(RD(RFHGXH"?@A@AY"A X( GR `" `H$A P G" M.Tussis, M.Carminative 2.9 Y 1"% (Lotion) W\"()Y`H@A D$P G z@]"A Calamine lotion, T.A. lotion, Acne lotion 2.10 J2%2 (Enema) W\L@"()S&()XNOPSGRHSXA Unison enema 2.11 Vaginal Douche W\L@"LHGR R%$ NLWX' pH Lv &( L$X'ADO Lactacyd 2.12 #/! ' ^Q # -0 (Sterile product) () A& D$ R i "zN$ D$ Ri
3. !"#$%_"& 3.1 ,!' (Cream) W\"NX XO D$AJORY`#R &(%N?@ s AH "`N(KJ(R &(%NYK A@?"'KDHSXRR "Y@GR()AR " T.A. cream 3.2 !0@_0 (Ointment) W\"AJORY`#RNO &(" SN"HPL NX(R D$NO W\X/F W\X Diprosalic ointment, Whitfield ointment 3.3 #Q (Gels) W\"AJORY`#RNO &("NXAZ_@PLF W\XY@GR()AR " Hirudoid gel, Voltaren emulgel 3.4 a (Pastes) NXAZ_@%G"%NS& ointment NL HKL`RKRYWR)PSG$I$X'`R SHF$G$N zinc oxide paste P GAX'YKP R WA triamcinolone oral paste
4. -"% b 4.1J((' (Inhalation dosage forms )
3 P GLI$"S&$" `GFWR $DS"P? (R%/?IA) Q$"X" %&OR&D Z &OL R" Metered dose inhaler (MI) N XH"Y@LKXA$XAo SHPSG"A Ventolin Inhaler (Ventolin Evohaler) VG W\ D$LI$KR N"AH Turbuhaler S& Accuhaler 4.2 %8 J @2%1 (Transdermal therapeutic system-TTS) W\" D$YW@KDHSXRPSG `GLI RA"P@"@ HNOA)S$ SGY' RQ$"AX$YK " @?))PSGAABCDE`R" WNO"FW Nitroderm TTS, Nicotinelle, Climera, Durogesic TTS , Exelon Patch
4.3 ef (Implant dosage forms ) NXH"ABCDEL)%Xg"I AX' polymer L$ `GPGKDHSXRQ$"AK X$ NAW$W "XH"" R Gi W\ H "MfR%sA) D$ Implanon 5 W Jadelle 3 W
(Root of administration) 1 Oral route W\HDCNNOD"P GANOLs$ @L@$HA Y@KIGW^H"LVP G$GH" RF$G Y N`G LN"%& P G HPA DOABCDE K`RAXAZF Y @"$I$J?A@''R $DS "? AD$WDADD"AX'"&OS&S Y@"VIA)" Q$"AVIA$I$JK X' F WNO"IWJOR"XR%RNBCDES&S$BCDEF$G 2. Buccal route "VIA$I$JK S$ &$M"Y@N()" H"@"XH" NX(R D$PGD(JOR?@ABCDE #H Y A#S$BCDE #H D$ `GRA@sGRYAGS&DMWA'AX' SR&A JOR?@ DOABCDE GAH Y "?@ABCDEF$GAH KIGW^H"F %H'GH()" Y@""A&()"PSGG"NOLs$ ?JR?@F$GKAXAZNO$N 3. Inhalation route "VIALI$ `GRWAS&?IA JORLVABCDEXOH RA" DLsD D$LI$ Y@ D$ABCDE z@NO "`"" S$ "?@VIA$I$JF$G" RH$ #H @PW$N LG &$M""I ?)HA 4. Nasal route "VIALI$ `GR?IA JORLVABCDEXOH RA" Miacalcic nasal spray Y@ D$ABCDE z@NO " Nasal decongestant 5. Topical route W\APSG"NOKDHSXR JORL HAPSGAXAZY'' z@NO " D$%N Y N'R D$ABCDEXOH RA" Ostrogel cream "HA Transdermal drug delivery system JOR?@GRNQ%RLGR`RYK YW@KDHSXRNOAY'' Q$" z@ PSGNL HAXA A#'XH"FHG]"P L HNO"J$D$AX'KDHSXRNYK AHY@YK '%H'%sAW$W "XH" &OPSG"$I$J `G RA"PWD_NOA)S$" RLO) L GRD$'D H_NO"$I$JF$G$N SGP G'D H_NONYKVA @ ?F$GX'" AD`$F$G
4 6. Rectal route W\APSG"RHSXA JORLVABCDEXOH RA" F$G Q$"$I$JK LG &$NO N("R)FLGPSg L HW" cyclogest suppo Y@ W\R &AL)SX'KIGNOF LVX'W@"F$G gravol suppo S&ABCDE z@NO proctosedyl Y NKIGW^H"'R"F 'P G 7. Vaginal route L HPSg P GL)SX'AABCDE z@NO Canesten VT Y N"s PS NOP GL)SX'PSGABCDEXOH RA" F$G Vagifem suppo. 8. Parenteral route "zN$ S@L)SX'ASHXRKPSG"ABCDE #H N"S" D$NOF LVPSGQ$"HDCN&OF$G ?JR?) W\GRPSGQ$"AzN$ L Ss W\"NO L&OL"F$GR " &OLXKXLAX'()" "P@''R $DS W\"NONIWY'' z@F LV N" W\ "&OF$G HX%N |7Q'R D$ Q$"Y' R W\AzN$ D$ Ri 8.1 j!(#+ #J+%# -((8 IV (Intaveneous root) "?@ABCDE #HA @F K `'HA$I$J Y ? AD$ K LN"%& ?)PSG AD$A@%" %&RS$ &$ &( "&O'D H_NOPSG"?D$ &( VGYG"?@NANOsYRAH A X'W@" 8.2 j!(#+ ./+@2%1 Sc (Subcutaneous root) zN$ `GPGKDHSXR X( dermis P GAX'"WD_O))PSGF @%" %&R XH"?@% "i W "AY@VIA$I$J `GA@YL &$ `G LN"-"'R D$?)PSG AD$AWH$ AD$A@%" R &( "&O AD$ W\YKS&M'D H_NOzo$F$G
8.3 j!(#+ + '#%-0 IM (Intramuscular root) NX(R D$()PL(ABCDE #H) Y@ D$ suspensions ABCDE G Y "I F$G 'R D$LVABCDEF$GVJR 3 $& A$I$J"A`J(AX'Wf??X" Ri AAA)XR AH$ A 'S&AW@%'$GH"%HG AzN$" `GAGY`"?@VIA$I$JF$G #HAH AzN$'D H_L@QA "zN$ D$ `GAGNOGRAPSGABCDEF$G ?@HXH AD$ W\AG N"AH depot MfR"I PAG &(L HX( "?JR % "i W$W "A ABCDEF$G W\ $&i 8.4 j!(#+ + IA (Intraarticular) zN$LS &OHA hyalulonate `G`G AzN$" steroid `G`G 9. EENT route (Eye Ear Nose Throat) "S"$Y@SI?) W\GRNAWX'%HJR tonicity &OPSG `GAX'`R SHP RA" &OF PSG AD$%H@%" %&R Q$"A?@PSGN isotonic
5 l ,@%2 @%@1 ((:_' %(1 %
#J + 1. IWY''`R"Y@ RRA'DS `N"Q$" . ]A. AN Y HDHXAs 2. 'IG &OR"Y@KD]X_7Ls`]..."DOR`J( `N"Q$" ]g. $. XAZ_ YXAs ?ASXRL& 'IG &OR"Y@KD]X_7 Ls`] 2 %_@ ]LX L7 SHD"X"N%DHDQ .. 2551 3. " #$IWY''D Z `N"Q$" ]g. X7 HDD"@Q?7 ?ASXRL& 'IG &OR"Y@KD]X_7Ls`] 2 %_@ ]LX L7 SHD"X"N%DHDQ .. 2551 4. %HIG '&(RGR ]LX HD"Y@IWY''" N" `N"Q$" . ]A. DL ?sN
6